arrow
G

Gianmarco Piccinno

university of trento
H指数:11
被引数:3,329

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microbiome alterations in mismatch-repair deficient metastatic colorectal cancer patients

错配修复缺陷型转移性结直肠癌患者中的微生物组改变

2026-09-010
OAAI
Feasibility and Compliance of Stool Collection for Future Microbiome-Based Colorectal Cancer Screening: Preliminary Findings from a Prospective Multicenter FIT-Positive Cohort

粪便样本收集用于未来基于微生物组的结直肠癌筛查的可行性与依从性:一项前瞻性多中心FIT阳性队列的初步发现

2026-08-190
OAAI
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

通过血浆谱分析确定的癌症免疫治疗结果的代谢决定因素

2026-06-250
OAAI
Long-lasting gut microbiome and fecal metabolome alterations after colorectal adenoma removal and their relationship to colorectal cancer

结直肠腺瘤切除后持久的肠道微生物组和粪便代谢组改变及其与结直肠癌的关系

2026-05-270
OAAI
Biodiversity and biogeography of the multi-kingdom cancer microbiome

多界癌症微生物组的生物多样性与生物地理学

Cell
IF42.5
2026-05-050
PRE
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

粪便菌群移植联合免疫治疗非小细胞肺癌和黑色素瘤: fmt-luminate 2期临床试验

2026-01-280
OAAI
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial

粪便菌群移植联合pembrolizumab和阿昔替尼治疗转移性肾细胞癌: 随机2期TACITO试验

2026-01-280
PRE
Integrative analyses of dicarbonyls and advanced glycation end-products with multiomic profiles across tissue, plasma and stool samples reveal methylglyoxal accumulation in colon cancer
2026-01-220
OAAI
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
2026-01-070
OAAI
Meta-analysis of 22,710 human microbiome metagenomes defines an oral-to-gut microbial enrichment score and associations with host health and disease

22,710份人类微生物组元基因组荟萃分析定义了口腔至肠道微生物富集评分及其与宿主健康和疾病的关系

2025-12-230
OAAI
Gut micro-organisms associated with health, nutrition and dietary interventions

与健康、营养和饮食干预相关的肠道微生物

Nature
IF48.5
2025-12-100
OAAI
Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer

Piccinno, G.; Thompson, K.N.; Manghi, P.; Ghazi, A.R.; Thomas, A.M.; Blanco-Miguez, A.; Asnicar, F.; Mladenovic, K.; Pinto, F.; Armanini, F.; et al. 对来自18个队列的3,741份粪便元基因组进行合并分析,以确定结直肠癌的可复现的跨阶段和菌株水平微生物生物标志物。Nat. Med. 2025, 31, 2416–2429. [Google Scholar] [CrossRef] [PubMed]

2025-06-030
OAAI
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers

与晚期癌症生存相关的肠道功能障碍的替代标志物

2025-04-060
OAAI
Fusobacterium sphaericum sp. nov., isolated from a human colon tumor adheres to colonic epithelial cells and induces IL-8 secretion

球形梭杆菌新种 (Fusobacterium sphaericum sp. nov.),该菌株分离自人结肠肿瘤,可黏附于结肠上皮细胞并诱导IL-8分泌。

2024-12-252
OA
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial

基于随机佐剂树突状细胞的mind-dc试验中微生物相关代谢重编程对黑色素瘤患者临床结局的影响

2024-02-236
OAAI
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial (vol 29, pg 2121, 2023 )

晚期黑色素瘤的粪便微生物群移植加anti-PD-1免疫疗法: I期试验 (第29卷,2121页,2023页)

2023-11-031
OA
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

晚期黑色素瘤的粪便菌群移植加anti-PD-1免疫治疗: I期试验

2023-07-06118
PRE
MetaPhlAn 4 profiling of unknown species-level genome bins improves the characterization of diet-associated microbiome changes in mice

未知物种水平基因组的metaplan 4分析可改善小鼠饮食相关微生物组变化的特征

2023-05-0111
OAAI